loading...| Preferred Name |
amprenavir |
|
| Synonyms |
[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate |
|
| Definitions |
This is any condition in which the main influencing factor is amprenavir, a protease inhibitor designed to treat HIV infections. Amprenavir has been replaced by fosamprenavir, a prodrug of amprenavir. |
|
| ID |
http://purl.obolibrary.org/obo/XCO_0001130 |
|
| created_by |
slaulederkind |
|
| creation_date |
2023-11-20T18:47:45Z |
|
| database_cross_reference |
CHEBI:40050 MESH:C095108 |
|
| definition |
This is any condition in which the main influencing factor is amprenavir, a protease inhibitor designed to treat HIV infections. Amprenavir has been replaced by fosamprenavir, a prodrug of amprenavir. |
|
| has_exact_synonym |
[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate |
|
| has_obo_namespace |
experimental_condition_ontology |
|
| id |
XCO:0001130 |
|
| label |
amprenavir |
|
| notation |
XCO:0001130 |
|
| prefLabel |
amprenavir |
|
| treeView | ||
| subClassOf |